---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-071880"
form_type: "8-K"
ticker: "CLDX"
cik: "0000744218"
company_name: "Celldex Therapeutics, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:26:07.436516+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Celldex shareholders elect all director nominees, ratify auditor, approve executive compensation at 2022 annual meeting

## Summary
- All 8 director nominees elected; Karen L. Shoos received 39.9M votes for, 1.0M withheld.
- Ratification of PricewaterhouseCoopers as auditor for FY2022 approved with 43.3M votes for.
- Advisory say-on-pay approved: 40.0M for, 717k against, 180k abstain.
- Broker non-votes of 2.5M shares on director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0001104659-22-071880
- form_type: 8-K
- ticker: CLDX
- cik: 0000744218
- company_name: Celldex Therapeutics, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744218/000110465922071880/0001104659-22-071880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744218/000110465922071880/tm2218670d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-071880
- JSON: https://secwatch.observer/filing/0001104659-22-071880.json
- Plain text: https://secwatch.observer/filing/0001104659-22-071880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.